ArticleCureus2025
Health-Related Quality of Life in Patients With Type 2 Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Health-related quality of life among patients with type 2 diabetes mellitus using EuroQol five-dimension five level: A cross-sectional study from an urban health training center, Coimbatore, India.Journal of education and health promotion · 2026Article
- Real-world effectiveness, safety, and quality of life of biosynthetic semaglutide in Pakistani adults with type 2 diabetes mellitus: a study protocol.Journal of pharmaceutical policy and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople with type 2 diabetes mellitus (T2DM) can have both physical and mental problems that tend to lower their health-related quality of life (HRQoL). While T2DM is a serious issue for health worldwide, not much is known about its influence on the quality of life (QoL) for patients in Pakistan. The main goal of this study is to measure the QoL in patients with T2DM in Pakistan and to see how a range of factors can impact their HRQoL.
methodsThe research involved completing a cross-sectional study of 385 patients with T2DM from outpatient and diabetes care centers in Pakistan. Information was gathered using both the Diabetes Quality of Life Questionnaire (QoL-Q Diabetes) and the Short Form-36 Health Survey (SF-36). Both tests, i.e., Kolmogorov-Smirnov and Shapiro-Wilk, were applied to check if the data followed the usual pattern. It also used descriptive statistics, Pearson correlation, independent samples t-tests, one-way ANOVA, chi-square tests, and linear regression methods. We used IBM SPSS Statistics version 26, along with a p-value lower than 0.05, when carrying out statistical analysis. The interview process took place from November 2024 to April 2025.
resultsThe analysis pointed out that scores for HRQoL varied significantly depending on the period of the disease, the care offered, and whether there were complications. On the Pearson correlation, a small and noticeable relationship (r = 0.074, p < 0.001) was found between the QoL-Q Diabetes and SF-36 scores. Those who lived with diabetes and treated it with insulin for a long time had scores that were somewhat lower for HRQoL. Although several differences between groups were statistically significant, their effect sizes were small, suggesting limited clinical relevance. The gaps that were noted in the study were mostly small in real-life situations. People who suffer from additional health problems, such as nephropathy and neuropathy, live with a noticeably lower HRQoL.
conclusionIn conclusion, our research shows that T2DM has a moderate influence on patients' HRQoL in Pakistan. The most important factors influencing this are the type of treatment, the duration of T2DM, and any complications that develop. Although some group differences were statistically significant, the effect sizes were small, indicating minimal clinical impact. Therefore, individualized and comprehensive care remains essential to improve patients' overall QoL meaningfully.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.